Are the effects of nicotinic acid on insulin resistance precipitated by abnormal phosphorous metabolism?

AUTOR(ES)
FONTE

BioMed Central

RESUMO

Nicotinic acid is a unique cholesterol modifying agent that exerts favorable effects on all cholesterol parameters. It holds promise as one of the main pharmacological agents to treat mixed dyslipidemia in metabolic syndrome and diabetic patients. The use of nicotinic acid has always been haunted with concerns that it might worsen insulin resistance and complicate diabetes management.

Documentos Relacionados